MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Avanos Medical Accounts Receivables 2011-2026 | AVNS
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables Avanos Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104 M | 133 M | 143 M | 168 M | 131 M | 109 M | 164 M | 150 M | 203 M | 190 M | 225 M | 234 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 234 M | 104 M | 163 M |
Quarterly Accounts Receivables Avanos Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112 M | 110 M | 105 M | 133 M | 132 M | 123 M | 131 M | 143 M | 145 M | 152 M | 143 M | 168 M | 146 M | 145 M | 162 M | 131 M | 118 M | 107 M | 105 M | 109 M | 109 M | 109 M | 109 M | 152 M | 158 M | 164 M | 164 M | 150 M | 150 M | 150 M | 150 M | 203 M | 203 M | 203 M | 203 M | 188 M | 190 M | 190 M | 190 M | 225 M | 225 M | 225 M | 225 M | 234 M | 234 M | 234 M | 234 M | 203 M | 203 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 234 M | 105 M | 163 M |
Accounts Receivables of other stocks in the Medical devices industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
17.9 M | $ 3.42 | -2.43 % | $ 128 M |  France |
 |
Acutus Medical
AFIB
|
11.4 M | - | -26.83 % | $ 2.62 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
371 M | $ 11.96 | -0.95 % | $ 1.62 B | USA |
 |
Allied Healthcare Products
AHPI
|
2.37 M | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
6.55 M | $ 9.14 | -2.56 % | $ 259 M | USA |
 |
Globus Medical
GMED
|
679 M | $ 90.44 | 2.08 % | $ 12.2 B | USA |
 |
Bruker Corporation
BRKR
|
566 M | $ 36.34 | -1.09 % | $ 5.42 K | USA |
 |
Helius Medical Technologies
HSDT
|
117 K | $ 1.79 | -5.79 % | $ 1.09 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
272 M | $ 9.29 | -0.21 % | $ 715 M | USA |
 |
Inspire Medical Systems
INSP
|
120 M | $ 54.5 | 0.66 % | $ 1.6 B | USA |
 |
IRIDEX Corporation
IRIX
|
7.61 M | $ 1.0 | 0.34 % | $ 16.9 M | USA |
 |
Integer Holdings Corporation
ITGR
|
346 M | $ 85.22 | -0.48 % | $ 2.96 B | USA |
 |
Apollo Endosurgery
APEN
|
15 M | - | - | $ 475 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
53.8 M | $ 15.7 | -1.54 % | $ 368 M | USA |
 |
LENSAR
LNSR
|
6.38 M | $ 5.83 | -1.1 % | $ 69.7 M | USA |
 |
Medtronic PLC
MDT
|
6.52 B | $ 86.5 | 0.25 % | $ 111 B | USA |
 |
Myomo
MYO
|
4.1 M | $ 0.67 | -5.3 % | $ 28 M | USA |
 |
Avinger
AVGR
|
1.01 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
996 M | $ 167.2 | -2.72 % | $ 12.5 B | USA |
 |
Orthofix Medical
OFIX
|
136 M | $ 11.72 | -0.4 % | $ 464 M |  Curacao |
 |
AxoGen
AXGN
|
26.2 M | $ 30.54 | -6.43 % | $ 1.41 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
44.8 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
1.73 M | - | 1.37 % | $ 20.5 M | USA |
 |
Insulet Corporation
PODD
|
161 M | $ 204.83 | 0.65 % | $ 14.4 B | USA |
 |
Sintx Technologies
SINT
|
178 K | $ 2.63 | 3.95 % | $ 7.29 M | USA |
 |
Butterfly Network
BFLY
|
20.8 M | $ 4.0 | -3.27 % | $ 847 M | USA |
 |
Stryker Corporation
SYK
|
4.04 B | $ 331.21 | -0.33 % | $ 127 B | USA |
 |
Tactile Systems Technology
TCMD
|
43.9 M | $ 24.24 | -1.38 % | $ 554 M | USA |
 |
Cytosorbents Corporation
CTSO
|
7.55 M | $ 0.6 | 1.68 % | $ 37.3 M | USA |
 |
TELA Bio
TELA
|
10.3 M | $ 0.68 | 7.69 % | $ 31.9 M | USA |
 |
TransMedics Group
TMDX
|
84.3 M | $ 107.12 | 2.21 % | $ 3.64 B | USA |
 |
Tandem Diabetes Care
TNDM
|
165 M | $ 18.93 | -1.28 % | $ 1.29 B | USA |
 |
BIOLASE
BIOL
|
5.48 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
11.7 M | $ 9.66 | -0.41 % | $ 346 M | USA |
 |
BioSig Technologies
BSGM
|
109 K | - | 37.08 % | $ 85.7 M | USA |
 |
Alphatec Holdings
ATEC
|
97.3 M | $ 11.14 | 1.55 % | $ 1.67 B | USA |